Cargando…

Diet in Scleroderma: Is There a Need for Intervention?

Systemic sclerosis (SSc) patients exhibit a plethora of risk factors for nutritional decline, including the presence of chronic inflammation and the progressive nature of disease-related multisystem involvement. The prevalence and consequences of nutritional decline in scleroderma are frequently und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burlui, Alexandra Maria, Cardoneanu, Anca, Macovei, Luana Andreea, Rezus, Ciprian, Boiculese, Lucian Vasile, Graur, Mariana, Rezus, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620611/ https://www.ncbi.nlm.nih.gov/pubmed/34829464 http://dx.doi.org/10.3390/diagnostics11112118

Ejemplares similares

Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background
por: Rezuș, Elena, et al.
Publicado: (2021)

The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review
por: Bratoiu, Ioana, et al.
Publicado: (2022)

From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside
por: Rezuş, Elena, et al.
Publicado: (2021)

Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment
por: Macovei, Luana Andreea, et al.
Publicado: (2022)

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
por: Richter, Patricia, et al.
Publicado: (2023)

A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study
por: Rezus, Elena, et al.
Publicado: (2020)

Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?
por: Cardoneanu, Anca, et al.
Publicado: (2022)

Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?
por: Richter, Patricia, et al.
Publicado: (2022)

Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus
por: Richter, Patricia, et al.
Publicado: (2022)

Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17
por: Richter, Patricia, et al.
Publicado: (2023)

Characteristics of the intestinal microbiome in ankylosing spondylitis
por: Cardoneanu, Anca, et al.
Publicado: (2021)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

Temporomandibular Joint Osteoarthritis: Pathogenic Mechanisms Involving the Cartilage and Subchondral Bone, and Potential Therapeutic Strategies for Joint Regeneration
por: Cardoneanu, Anca, et al.
Publicado: (2022)

Multicentric Reticulohistiocytosis Exhibiting Positive HLA-B*07 and HLA-B*08: A Case Report
por: Rezuș, Elena, et al.
Publicado: (2020)

Inactivity and Skeletal Muscle Metabolism: A Vicious Cycle in Old Age
por: Rezuş, Elena, et al.
Publicado: (2020)

The Link Between Inflammaging and Degenerative Joint Diseases
por: Rezuș, Elena, et al.
Publicado: (2019)

Adult-onset Still's disease and the role of dermatological manifestations: A case report and literature review
por: Vâță, Andrei, et al.
Publicado: (2021)

Idazoxan and Efaroxan Potentiate the Endurance Performances and the Antioxidant Activity of Ephedrine in Rats
por: Rusu-Zota, Gabriela, et al.
Publicado: (2021)

QT interval variations and mortality risk: Is there any relationship?
por: Rezuş, Ciprian, et al.
Publicado: (2015)

Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI)
por: Tanase, Daniela Maria, et al.
Publicado: (2021)

Osteonecrosis of the Femoral Head in Patients with Hypercoagulability—From Pathophysiology to Therapeutic Implications
por: Rezus, Elena, et al.
Publicado: (2021)

MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New?
por: Tanase, Daniela Maria, et al.
Publicado: (2022)

Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy
por: Popescu, Diana, et al.
Publicado: (2023)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers
por: Cojocaru, Florina-Daniela, et al.
Publicado: (2020)

Predictors Associated with Adverse Pregnancy Outcomes in a Cohort of Women with Systematic Lupus Erythematosus from Romania—An Observational Study (Stage 2)
por: Vicoveanu, Petronela, et al.
Publicado: (2022)

Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

Intracerebroventricular Coadministration of Protoxin-II and Trace Elements in Rats Enhances the Analgesic Effect of the 1.7 Voltage-Gate Sodium Channel Blocker
por: Stanciu, Gabriela-Dumitrita, et al.
Publicado: (2019)

Hyponatremia—Long-Term Prognostic Factor for Nonfatal Pulmonary Embolism
por: Ouatu, Anca, et al.
Publicado: (2021)

Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia
por: Badescu, Minerva Codruta, et al.
Publicado: (2021)

From Pathogenesis to Treatment—New Perspectives in Rheumatology
por: Rezus, Elena, et al.
Publicado: (2023)

Modulation of the activity of certain genes involved in tumor cell metabolism in the presence of the cytotoxic peptides defensin and cathelicidin LL37
por: Ștefanache, Teodor, et al.
Publicado: (2019)

Impact of cardiac rehabilitation programs on left ventricular remodeling after acute myocardial infarction: Study Protocol Clinical Trial (SPIRIT Compliant)
por: Susca, Mihaela Ghircau, et al.
Publicado: (2020)

Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2022)

Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2023)

The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
por: Tudorancea, Ivona Maria, et al.
Publicado: (2022)

Impact of inflammation-mediated response on pan-coronary plaque vulnerability, myocardial viability and ventricular remodeling in the postinfarction period - the VIABILITY study: Protocol for a non-randomized prospective clinical study
por: Morariu, Mirabela, et al.
Publicado: (2019)

Myocardial Ischemia Related to Common Cancer Therapy—Prevention Insights
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications
por: Tanase, Daniela Maria, et al.
Publicado: (2023)

Cardiac Implantable Electronic Devices in Different Anatomical Types of Persistent Left Superior Vena Cava: Case Series and Brief Review of the Literature
por: Adavidoaei, Cosmin Gabriel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0hrmvsg006b43cj1pmt9o8ppcb